Summit Therapeutics

Summit Therapeutics PEG

The PEG Ratio (Price/Earnings-to-Growth) of Summit Therapeutics (SMMT) as of Nov 22, 2026 is 39.39.

PEG

39.39

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Summit Therapeutics is 2018 39.39 . PEG Ratio (Price/Earnings-to-Growth) of Summit Therapeutics was 2017 - . It decreases by % lower compared to the previous year.

The Summit Therapeutics PEG history

The Summit Therapeutics PEG history
YEARPEGYoY
39.39—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Summit Therapeutics Stock analysis

What does Summit Therapeutics do? Summit Therapeutics Inc. is a global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines for the treatment of life-threatening and rare diseases. The company is headquartered in Massachusetts, USA and also has offices in Oxford, UK. Summit Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Summit Therapeutics stock

PEG Ratio (Price/Earnings-to-Growth) of Summit Therapeutics is 39.39 in 2018.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Summit Therapeutics since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Summit Therapeutics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Summit Therapeutics

All Key Metrics — Summit Therapeutics